Shandong Boan says China CDE accepts IND filing for BA1203 masked anti-PD-1/IL-2 fusion proteinPUBT·Jul 7 at 11:01 PM06955-0.96%
Shandong Boan Wins CDE Nod for Phase II Lung Cancer Trial of Novel Immunotherapy ComboTip Ranks·Jul 2 at 06:38 AM06955-0.96%
Shandong Boan Biotech shareholders adopt restricted share unit incentive scheme at AGMPUBT·Jun 22 at 08:01 AM06955-0.96%
Boan Biotech Wins New China Approval for Denosumab Biosimilar, Accelerates Global PushTip Ranks·May 25 at 11:37 PM06955-0.96%
"Performance" BOAN BIOTECH's annual net profit is 7.14 million RMB, down 90.2%, no dividend declaredAASTOCKS·Mar 30 at 11:39 AM588130-2.14%159615-1.56%
BOAN BIOTECH's controlling shareholder plans to further transfer 38.5 million sharesAASTOCKS·Jan 21 at 08:20 AM513060-1.14%159892-1.40%
Boan Biotech Explains Trading Surge as Share Transfer and Wins Bolivia Nod for Denosumab BiosimilarTip Ranks·Jan 11 at 04:37 AM06955-0.96%
Morning Trend | BOAN BIOTECH's trading volume is sluggish, and the rebound window has not appeared under cautious capital?Technical Forecast·Dec 3, 2025 at 07:00 PM06955-0.96%
